Orton Orthopaedic Hospital, Tenholantie 10, 00280, Helsinki, Finland.
Musculoskeletal and Plastic Surgery department, Helsinki University Hospital, Helsinki, Finland.
Eur J Orthop Surg Traumatol. 2023 May;33(4):1411-1420. doi: 10.1007/s00590-022-03299-8. Epub 2022 Jun 14.
Treatment of secondary knee osteoarthritis with a significant extra-articular deformity can be challenging. In such cases, an osteotomy or a custom-made hinged knee arthroplasy (CMH) are treatment options. However, there are limited data on the outcomes of using CMHs. Thus, the aim of this retrospective study was to assess the clinical results and subjective outcomes of CMHs.
We reviewed 9 CMHs (Endo-Model, LINK) in 7 patients with a minimum of 2-year follow-up. Upon the last follow-up, we evaluated MA, stability and range of movement (ROM). Oxford Knee Score (OKS) was used to evaluate patient-reported outcomes.
The average age upon surgery was 61 years (48-76 years), and the follow-up period was 66 months. There were no early complications. Two CMHs were revised, one due to aseptic loosening and one due to late-onset haematogenic infection. Pre-operatively, MA varied from 18° (average 11°) valgus-deformity to 30° (average 17°) varus-deformity. Post-operatively, 7/9 (78%) of patients achieved better MA. Upon follow-up, the average OKS was 41/48, and ROM was 113°.
Patients treated with CMHs achieved good clinical and patient-reported outcomes. There were no early reoperations, and revision rate was relatively low. Overall, CMH could be considered for low-demand patients with increased operative risks.
对于存在明显关节外畸形的继发性膝关节骨关节炎的治疗具有挑战性。在这种情况下,截骨术或定制铰链式膝关节置换术(CMH)是治疗选择。然而,关于使用 CMH 的结果数据有限。因此,本回顾性研究的目的是评估 CMH 的临床结果和主观结果。
我们回顾了 7 名患者的 9 例 CMH(Endo-Model,LINK),随访时间至少为 2 年。在最后一次随访时,我们评估了 MA、稳定性和活动范围(ROM)。使用牛津膝关节评分(OKS)评估患者报告的结果。
手术时的平均年龄为 61 岁(48-76 岁),随访时间为 66 个月。没有早期并发症。有 2 例 CMH 需要翻修,其中 1 例因无菌性松动,1 例因迟发性血源性感染。术前,MA 从 18°(平均 11°)的外翻畸形到 30°(平均 17°)的内翻畸形不等。术后,7/9(78%)例患者的 MA 得到改善。随访时,平均 OKS 为 41/48,ROM 为 113°。
接受 CMH 治疗的患者获得了良好的临床和患者报告的结果。没有早期再次手术,翻修率相对较低。总体而言,CMH 可考虑用于具有较高手术风险的低需求患者。